BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meyn RE, Stephens LC, Hunter NR, Milas L. Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer. 1995;60:725-729. [PMID: 7860148 DOI: 10.1002/ijc.2910600526] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Bodiga VL, Bodiga S, Surampudi S, Boindala S, Putcha U, Nagalla B, Subramaniam K, Manchala R. Effect of vitamin supplementation on cisplatin-induced intestinal epithelial cell apoptosis in Wistar/NIN rats. Nutrition 2012;28:572-80. [PMID: 22189195 DOI: 10.1016/j.nut.2011.09.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
2 Vijayalakshmi B, Sesikeran B, Udaykumar P, Kalyanasundaram S, Raghunath M. Chronic low vitamin intake potentiates cisplatin-induced intestinal epithelial cell apoptosis in WNIN rats. World J Gastroenterol 2006; 12(7): 1078-1085 [PMID: 16534849 DOI: 10.3748/wjg.v12.i7.1078] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
3 Gammon ST, Engel BJ, Gores GJ, Cressman E, Piwnica-Worms D, Millward SW. Mistiming Death: Modeling the Time-Domain Variability of Tumor Apoptosis and Implications for Molecular Imaging of Cell Death. Mol Imaging Biol 2020;22:1310-23. [PMID: 32519246 DOI: 10.1007/s11307-020-01509-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jiang Z, Chen BA, Xia GH, Wu Q, Zhang Y, Hong TY, Zhang W, Cheng J, Gao F, Liu LJ, Li XM, Wang XM. The reversal effect of magnetic Fe3O4 nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells. Int J Nanomedicine 2009;4:107-14. [PMID: 19516889 DOI: 10.2147/ijn.s5393] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
5 Lili Y, Zehua W. Difference in expression of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and cisplatin-resistant human in ovarian cancer cell lines. J Huazhong Univ Sci Technol [Med Sci ] 2004;24:151-3. [DOI: 10.1007/bf02885416] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Yin A, Jiang Y, Zhang X, Zhao J, Luo H. Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo. European Journal of Pharmacology 2010;649:120-6. [DOI: 10.1016/j.ejphar.2010.09.040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
7 Fu X, Tian J, Zhang L, Chen Y, Hao Q. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett. 2012;586:1279-1286. [PMID: 22465665 DOI: 10.1016/j.febslet.2012.03.006] [Cited by in Crossref: 125] [Cited by in F6Publishing: 119] [Article Influence: 13.9] [Reference Citation Analysis]
8 Trejo-becerril C, Pérez-cárdenas E, Treviño-cuevas H, Taja-chayeb L, García-lópez P, Segura-pacheco B, Chávez-blanco A, Lizano-soberon M, González-fierro A, Mariscal I, Wegman-ostrosky T, Dueñas-gonzález A. Circulating nucleosomes and response to chemotherapy: An in vitro , in vivo and clinical study on cervical cancer patients: Serum Nucleosomes and Chemotherapy Response. Int J Cancer 2003;104:663-8. [DOI: 10.1002/ijc.11003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
9 Gibb RK, Taylor DD, Wan T, O'Connor DM, Doering DL, Gerçel-Taylor C. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines. Gynecol Oncol 1997;65:13-22. [PMID: 9103385 DOI: 10.1006/gyno.1997.4637] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sharova TY, Poterlowicz K, Botchkareva NV, Kondratiev NA, Aziz A, Spiegel JH, Botchkarev VA, Sharov AA. Complex changes in the apoptotic and cell differentiation programs during initiation of the hair follicle response to chemotherapy. J Invest Dermatol 2014;134:2873-82. [PMID: 24999588 DOI: 10.1038/jid.2014.267] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
11 Kurihara H, Yang DJ, Cristofanilli M, Erwin WD, Yu DF, Kohanim S, Mendez R, Kim EE. Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors. Appl Radiat Isot 2008;66:1175-82. [PMID: 18308577 DOI: 10.1016/j.apradiso.2008.01.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
12 Wang S, Tang S, Chen X, Li X, Jiang S, Li HP, Jia PH, Song MJ, Di P, Li W. Pulchinenoside B4 exerts the protective effects against cisplatin-induced nephrotoxicity through NF-κB and MAPK mediated apoptosis signaling pathways in mice. Chem Biol Interact 2020;331:109233. [PMID: 32991863 DOI: 10.1016/j.cbi.2020.109233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Espinosa A, Marchal JA, Aranega A, Gallo MA, Aiello S, Campos J. Antitumoural properties of benzannelated seven-membered 5-fluorouracil derivatives and related open analogues. Molecular markers for apoptosis and cell cycle dysregulation. Farmaco. 2005;60:91-97. [PMID: 15752467 DOI: 10.1016/j.farmac.2004.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
14 Joschko MA, Webster LK, Groves J, Yuen K, Palatsides M, Ball DL, Millward MJ. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model. Radiat Oncol Investig 1997;5:62-71. [DOI: 10.1002/(sici)1520-6823(1997)5:2<62::aid-roi4>3.0.co;2-h] [Cited by in Crossref: 37] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
15 O'Neill CF, Ormerod MG, Robertson D, Titley JC, Cumber-Walsweer Y, Kelland LR. Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex. Br J Cancer 1996;74:1037-45. [PMID: 8855971 DOI: 10.1038/bjc.1996.486] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yin Z, Mao Y, Zhang N, Su Y, Zhu J, Tong H, Zhang H. A fully chimeric IgG antibody for ROR1 suppresses ovarian cancer growth in vitro and in vivo. Biomed Pharmacother 2019;119:109420. [PMID: 31536932 DOI: 10.1016/j.biopha.2019.109420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Niu G, Zhu L, Ho DN, Zhang F, Gao H, Quan Q, Hida N, Ozawa T, Liu G, Chen X. Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis. Theranostics 2013;3:190-200. [PMID: 23471295 DOI: 10.7150/thno.5825] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
18 Vrána O, Boudný V, Brabec V. Superhelical torsion controls DNA interstrand cross-linking by antitumor cis- diamminedichloroplatinum(II). Nucleic Acids Res 1996;24:3918-25. [PMID: 8918792 DOI: 10.1093/nar/24.20.3918] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
19 Merlin J, Bour-dill C, Marchal S, Bastien L, Gramain M. Resistance to paclitaxel induces time-delayed multinucleation and DNA fragmentation into large fragments in MCF-7 human breast adenocarcinoma cells: . Anti-Cancer Drugs 2000;11:295-302. [DOI: 10.1097/00001813-200004000-00011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
20 Trejo-Becerril C, Oñate-Ocaña LF, Taja-Chayeb L, Vanoye-Carlo A, Cetina L, Duenas-Gonzalez A. Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance. BMC Cancer 2005;5:65. [PMID: 15982417 DOI: 10.1186/1471-2407-5-65] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
21 Yang DJ, Kim EE, Inoue T. Targeted molecular imaging in oncology. Ann Nucl Med. 2006;20:1-11. [PMID: 16485568 DOI: 10.1007/BF02985584] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
22 Meyn RE, Stephens LC, Milas L. Programmed cell death and radioresistance. Cancer Metastasis Rev 1996;15:119-31. [PMID: 8842483 DOI: 10.1007/BF00049491] [Cited by in Crossref: 55] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
23 Conejo-garcía A, Núñez MDC, Díaz-gavilán M, Cruz-lópez O, Gallo MÁ, Espinosa A, Campos JM. From 5-fluorouracil acyclonucleosides to benzo-fused six- and seven-membered rings linked to pyrimidine and purine bases: the shift from differentiating anticancer agents to apoptotic inducers. Expert Opinion on Drug Discovery 2008;3:1223-35. [DOI: 10.1517/17460441.3.10.1223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Tan SH, Lee SC. Clinical implications of chemotherapy-induced tumor gene expression in human breast cancers. Expert Opin Drug Metab Toxicol 2010;6:283-306. [PMID: 20163320 DOI: 10.1517/17425250903510611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Saniger E, Campos JM, Entrena A, Marchal JA, Suárez I, Aránega A, Choquesillo D, Niclós J, Gallo MÁ, Espinosa A. Medium benzene-fused oxacycles with the 5-fluorouracil moiety: synthesis, antiproliferative activities and apoptosis induction in breast cancer cells. Tetrahedron 2003;59:5457-67. [DOI: 10.1016/s0040-4020(03)00871-8] [Cited by in Crossref: 25] [Article Influence: 1.4] [Reference Citation Analysis]
26 Buchholz TA, Davis DW, Mcconkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Chemotherapy-Induced Apoptosis and Bcl-2 Levels Correlate with Breast Cancer Response to Chemotherapy: . The Cancer Journal 2003;9:33-41. [DOI: 10.1097/00130404-200301000-00007] [Cited by in Crossref: 97] [Cited by in F6Publishing: 93] [Article Influence: 5.4] [Reference Citation Analysis]
27 Fujimoto T, Maeda H, Kubo K, Sugita Y, Nakashima T, Sato E, Tanaka Y, Madachi M, Aiba M, Kameyama Y. Enhanced Anti-tumour Effect of Cisplatin with Low-voltage Electrochemotherapy in Hamster Oral Fibrosarcoma. J Int Med Res 2005;33:507-12. [DOI: 10.1177/147323000503300505] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
28 Buchholz TA, Stivers DN, Stec J, Ayers M, Clark E, Bolt A, Sahin AA, Symmans WF, Hess KR, Kuerer HM, Valero V, Hortobagyi GN, Pusztai L. Global gene expression changes during neoadjuvant chemotherapy for human breast cancer. Cancer J 2002;8:461-8. [PMID: 12500855 DOI: 10.1097/00130404-200211000-00010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
29 Moufarij MA, Phillips DR, Cullinane C. Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines. Mol Pharmacol. 2003;63:862-869. [PMID: 12644587 DOI: 10.1124/mol.63.4.862] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 3.1] [Reference Citation Analysis]
30 Ye W, Zhou Y, Xu B, Zhu D, Rui X, Xu M, Shi L, Zhang D, Jiang J. CD247 expression is associated with differentiation and classification in ovarian cancer. Medicine (Baltimore) 2019;98:e18407. [PMID: 31861005 DOI: 10.1097/MD.0000000000018407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
31 Jókay I, Soós G, Répássy G, Dezsõ B. Apoptosis in the human inner ear. Detection by in situ end-labeling of fragmented DNA and correlation with other markers. Hear Res 1998;117:131-9. [PMID: 9580436 DOI: 10.1016/s0378-5955(97)00215-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
32 Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, Coer A, Swartz HM, Cemazar M. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer. 2002;87:1047-1054. [PMID: 12434299 DOI: 10.1038/sj.bjc.6600606] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
33 Wheeler JA, Clifton Stephens L, Milas L, Hunter NR, Willingham VI, Meyn RE. Cisplatin-induced enhancement of radioresponse in a murine mammary carcinoma:Test of a role for apoptosis. Radiat Oncol Investig 1995;3:225-31. [DOI: 10.1002/roi.2970030505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
34 Kim YW, Kim EY, Jeon D, Liu JL, Kim HS, Choi JW, Ahn WS. Differential microRNA expression signatures and cell type-specific association with Taxol resistance in ovarian cancer cells. Drug Des Devel Ther 2014;8:293-314. [PMID: 24591819 DOI: 10.2147/DDDT.S51969] [Cited by in Crossref: 16] [Cited by in F6Publishing: 51] [Article Influence: 2.3] [Reference Citation Analysis]
35 Milross CG, Peters LJ, Hunter NR, Mason KA, Milas L. Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo. Int J Cancer 1995;62:599-604. [DOI: 10.1002/ijc.2910620518] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
36 Li J, Hu K, Gong G, Zhu D, Wang Y, Liu H, Wu X. Upregulation of MiR-205 transcriptionally suppresses SMAD4 and PTEN and contributes to human ovarian cancer progression. Sci Rep. 2017;7:41330. [PMID: 28145479 DOI: 10.1038/srep41330] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
37 Canada RG, Paltoo DN. Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1998;1448:85-98. [DOI: 10.1016/s0167-4889(98)00127-x] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
38 Caba O, Rodríguez-Serrano F, Díaz-Gavilán M, Conejo-García A, Ortiz R, Martínez-Amat A, Alvarez P, Gallo MA, Campos JM, Marchal JA, Aránega A. The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis. Eur J Med Chem 2012;50:376-82. [PMID: 22373735 DOI: 10.1016/j.ejmech.2012.02.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]